Kura Oncology
IPOThe promise of precision oncology brought to life for patients
Public · San Diego, United States · Founded 2014
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- kuraoncology.com
- Last Round
- Private EquityDec 2021
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing precision oncology therapies targeting RAS/MAPK pathway cancers.
Summary
Kura Oncology is a Biotech company based in San Diego, United States, founded in 2014. Its most recent funding was a Private Equity round in Dec 2021. Investors include EcoR1 Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...